Role of bacterial components in macrophage activation by the LAC and MW2 strains of community-associated, methicillin-resistant Staphylococcus aureus

Cellular Immunology

Volumn 269, Issue 1, 2011, Pages 46-53

  Spentzas, Thomas ^a,b   Kudumula, Ravi ^a,b   Acuna, Carlos ^a,b   Talati, Ajay J ^a,b   Ingram, Kimberly C ^a,b   Savorgnan, Fabio ^a,b   Meals, Elizabeth A ^a,b   English, B Keith ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

Daptomycin; Delta Toxin; Interleukin 12; Interleukin 6; MRSA; Panton Valentine Leukocidin; Phenol Soluble Modulins; Tumor Necrosis Factor; Vancomycin

Indexed keywords

BACTERIAL PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; PANTON VALENTINE LEUKOCIDIN; PHENOL; PHENOL SOLUBLE MODULIN PEPTIDE ALPHA; PHENOL SOLUBLE MODULIN PEPTIDE BETA; STAPHYLOCOCCUS TOXIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CYTOKINE RELEASE; GENE DELETION; MACROPHAGE; MACROPHAGE ACTIVATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RAW 264.7 MACROPHAGE;

ANIMALS; BACTERIAL TOXINS; EXOTOXINS; MACROPHAGE ACTIVATION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MURINAE;

EID: 79955470925     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.03.009     Document Type: Article

References (28)

1. Herold B.C., Immergluck L.C., Maranan M.C., Lauderdale D.S., Gaskin R.E., Boyle-Vavra S., Leitch C.D., Daum R.S. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279:593-598.
2. Centers for Disease Control and Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999, Morb Mortal Wkly Rep 48 (1999) 707-710.
3. Frank A.L., Marcinak J.F., Mangat P.D., Schreckenberger P.C. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 1999, 18:993-1000.
4. Sattler C.A., Mason Jr E.O., Kaplan S.L. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr. Infect. Dis. J. 2002, 21:910-917.
5. Lee C.M., Rio M.A., Fonseca A., Mejias A., Cavuoti D., McCraden H.G., Hardy D. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr. Infect. Dis. J. 2004, 23:123-127.
6. Buckingham S.C., McDougal L.K., Cathey L.D., Comeaux K., Craig A.S., Fridkin S.K., Tenover F.C. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr. Infect. Dis. J. 2004, 23:619-624.
7. Gonzalez B.E., Martinez-Aguilar G., Hulten K.G., Hammerman W.A., Coss-Bu J., Avalos-Mishaan A., Mason Jr E.O., Kaplan S.L. Severe staphylococcal sepsis in adolescence in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005, 115:642-648.
8. Adem P.V., Montgomery C.P., Husain A.N., Koogler T.K., Arangelovich V., Humilier M., Boyle-Vavra S., Daum R.S. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N. Engl. J. Med. 2005, 353:1245-1251.
9. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey B.B., Talan D.A. EMERGEncy ID NET Study Group, Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 2006, 355:666-674.
10. Arnold S.A., Elias D., Buckingham S.C., Thomas E.D., Novais E., Arkader A., Howard C. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J. Pediatr. Orthop. 2006, 26:703-708.
11. E. Klein, D.L. Smith, R. Laxminarayan, Community-associated methicillin-resistant Staphylococcus aureus in oupatients, United States, 1999-2006, Emerg. Infect. Dis. 15 (2009) 1925-1930.
12. Fast D.J., Schlievert P.M., Nelson R.D. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect. Immun. 1989, 57:291-294.
13. Nau R., Eiffert H. Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin. Microbiol. Rev. 2002, 15:95-110.
14. English B.K., Maryniw E.M., Talat A.J., Meals E.A. Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin. Antimicrob. Agents Chemother. 2006, 50:2225-2227.
15. Carpenter C.F., Chambers F.H. Daptomycin: another novel agent for treating infections due to drug resistant gram positive pathogens. Clin. Infect. Dis. 2004, 38:994-1000.
16. Steenbergen J.N., Aldrer J., Thorne M.G., Tally P.F. Daptomycin: a lipopeptide antibiotic in treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 2005, 55:283-288.
17. Cotroneo N., Harris R., Perlmutter N., Beveridge T., Silverman J.A. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob. Agents Chemother. 2008, 52:2223-2225.
18. Orman K.L., English B.K. Effects of antibiotic class on the macrophage inflammatory response to Streptococcus pneumoniae. J. Infect. Dis. 2000, 182:1561-1565.
19. Brinkman K.C., Talati A.J., Akbari R.E., Meals E.A., English B.K. Group B streptococci exposed to rifampin or clindamycin (versus ampicillin or cefotaxime) stimulate reduced production of inflammatory mediators by murine macrophages. Pediatr. Res. 2005, 57:419-423.
20. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.E., Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-valentine leukocidin genes: worldwide emergence. Emerg. Infect Dis. 2003, 9:978-984.
21. Kaplan S.L., Bocchini C.E., Hammerman W.A. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 2006, 117:433-440.
22. Gillet Y., Issartel B., Vanhems P., Fournet J.C., Lina G., Bes M., Vandenesch F., Piemont Y., Brousse N., Floret D., Etienne J. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
23. Voyich J.M., Otto M., Mathema B., Braughton K.R., Whitney A.R., Welty D., Long R.D., Dorward D.W., Gardner D.J., Lina G., Kreiswirth B.N., DeLeo F.R. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J. Infect. Dis. 2006, 194:1761-1770.
24. Bubeck Wardenburg J., Palazzolo-Ballance A.M., Otto M., Schneewind O., DeLeo F.R. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicilin-resistant Staphylococcus aureus disease. J. Infect. Dis. 2008, 198:1166-1170.
25. Wang R., Braughton K.R., Kretschmer D., Bach T-H, Queck S.Y., Li M., Kennedy A.D., Dorward D.W., Klebanoff S.J., Peschel A., DeLeo F.R., Otto M. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 2007, 13:1510-1514.
26. Tseng C.W., Kyme P., Low J., Rocha M.A., Alsabeh R., Miller L.G., Otto M., Arditi M., Diep B.A., Nizet V., Doherty T.M., Beenhouwer D.O., Liu G.Y. Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PloS One 2009, 4:e6387.
27. Diep B.A., Chan L., Tattevin P P., Kajikawa O., Martin T.R., Basuino L., Mai T.T., Marbach H., Braughton K.R., Whitney A.R., Gardner D.J., Fan X., Tseng C.W., Liu G.Y., Badiou C., Etienne J., Lina G., Matthay M.A., DeLeo F.R., Chambers H.F. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc. Natl. Acad. Sci. USA 2010, 107:5587-5592.
28. Brown E.L., Dumitrescu O., Thomas D., Badiou C., Koers E.M., Choudhury P., Vazquez V., Etienne J., Lina G., Vandenesch F., Bowden M.G. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin. Microbiol. Infect. 2009, 15:156-164.